PATENT CLAIM ANALYSIS

Application Number: 16206816
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["424", "093100"]

Abstract:
The present invention is directed to methods of inhibiting cancer cell growth or proliferation by contacting the cancer cell with an extracellular matrix (ECM) composition. Also provided are methods of delivering a chemotherapeutic agent to a cancer cell by contacting a cancer cell with an extracellular matrix composition containing a chemotherapeutic agent. Also provided are compositions containing ECM and a chemotherapeutic agent.

Claim (Index 13):
The method of  claim 12 , wherein the cancer is selected from the group consisting of melanoma, glioma, and adenocarcinoma, bladder cancer, bone cancer, cancer of the bone marrow, brain cancer, spinal cancer, breast cancer, cervical cancer, gall bladder cancer, cancer of the ganglia, cancer of the gastrointestinal tract, stomach cancer, colon cancer, cancer of the heart, kidney cancer, liver cancer, lung cancer, muscle cancer, ovarian cancer, pancreatic cancer, parathyroid cancer, cancer of the penis, prostate cancer, cancer of the salivary glands, skin cancer, cancer of the spleen, cancer of the testis, thymus cancer, thyroid cancer, or uterine cancer.

Metadata:
- Claim Count in Document: 63.0
- Percentile: 98.0
- Lexical Diversity: 1.86111
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12822126', '12363479', '15362261', '14711646', '12632721']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8244081002546133
- 35 USC 102 Novelty (BERT): 0.6077502804913514
- Combined Prediction Score: 0.8027423182782871
- Mean Citation Score: 528.459938
- Max Citation Score: 578.1101
- Similarity Product: 466.31485977607366

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test